vx-745 has been researched along with thymocartin in 1 studies
Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (thymocartin) | Trials (thymocartin) | Recent Studies (post-2010) (thymocartin) |
---|---|---|---|---|---|
58 | 1 | 35 | 18 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JY; Su, BC | 1 |
1 other study(ies) available for vx-745 and thymocartin
Article | Year |
---|---|
Pharmacological inhibition of p38 potentiates antimicrobial peptide TP4-induced cell death in glioblastoma cells.
Topics: Animals; Antimicrobial Cationic Peptides; Cell Death; Cell Line, Tumor; Female; Glioblastoma; Humans; Imidazoles; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pyridazines; Pyridines; Pyrimidines; Thymopoietins; Tilapia; Triple Negative Breast Neoplasms | 2020 |